Core Points - Emergent BioSolutions Inc. will be added to the Russell 3000 Index effective after the U.S. market closes on June 27, 2025, as part of the annual reconstitution of the Russell U.S. stock indexes [1][2] - The inclusion in the Russell 3000 Index is seen as a significant milestone in the company's transformation, indicating positive momentum and positioning for sustainable growth [2] - The Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks ranked by total market capitalization, with membership in the Russell 3000 Index providing automatic inclusion in either the large-cap Russell 1000 Index or small-cap Russell 2000 Index [2] Company Overview - Emergent BioSolutions has been focused on delivering protective and life-saving solutions for various health threats for over 25 years, including smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [5] - The company emphasizes its commitment to strong execution, financial stability, and long-term value creation for shareholders [2] Industry Context - Russell indexes are widely utilized by investment managers and institutional investors for index funds and as benchmarks for active investment strategies, with approximately $10.5 trillion in assets benchmarked against the Russell U.S. indexes as of December 2023 [3]

Core Insights - Emergent BioSolutions Inc. announced participation in several upcoming investor conferences, indicating active engagement with the investment community [1][3]. Company Overview - Emergent BioSolutions has a mission to protect and save lives, focusing on delivering solutions for health threats such as smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [2]. Upcoming Events - The company will participate in the RBC Global Healthcare Conference on May 20, 2025, with a fireside chat scheduled for 3:35 pm ET, available for virtual attendees via webcast [3]. - Emergent will also present at the Goldman Sachs Leveraged Finance Conference on May 29, 2025, in Dana Point, California [3]. - Additionally, the company is set to present at Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference on May 29, 2025 [3]. - The Jefferies Global Healthcare Conference presentation is scheduled for June 5, 2025, at 1:25 pm ET, also available for virtual participation [3].